A Yeast Model for Determining Tubulin-drug Interactions

描述(由申请人提供)：这项研究的总体目标是确定微管蛋白和微管稳定的抗有丝分裂药物之间的相互作用部位。紫杉醇是最广为人知的微管稳定化合物，但其他化合物，如埃博西酮，显示出巨大的抗肿瘤药物潜力。了解紫杉醇和其他具有类似紫杉醇活性的结构不同的抗有丝分裂化合物共有的结合部位将对合理设计与微管蛋白的紫杉醇结合区相结合的抗肿瘤药物有很大帮助。我们的方法是使用酵母微管蛋白的突变。虽然来自萌芽酵母的微管蛋白不与紫杉醇结合，但我们已经能够通过突变酵母和哺乳动物β-微管蛋白之间的124个氨基酸中的5个来产生与酵母微管蛋白强烈结合的紫杉醇。我们现在计划对紫杉醇结合区进行更全面的突变分析，以彻底了解紫杉醇、埃博西酮和其他化合物与该区域的β-微管蛋白结合所需的相互作用。我们计划确定我们造成的五个突变中的哪些是紫杉醇结合的最主要原因，以及其他哪些氨基酸也与紫杉醇结合有关，实际上起到了作用。我们将确定我们创造的突变是否影响紫杉醇结合、微管稳定性或两者兼而有之。我们的研究将确定微管稳定的抗有丝分裂药物紫杉醇、埃博西酮、紫杉醇和盘状核糖核酸与微管蛋白结合作用的差异。通过使用紫杉醇的光亲和类似物，我们将确定紫杉醇分子的哪一部分可能与β-微管蛋白的突变区域接触。最后，我们将研究来自裂解酵母Pombe的微管蛋白的紫杉醇结合特性，其中紫杉醇结合区域似乎更接近于哺乳动物的微管蛋白。

DESCRIPTION (provided by applicant): The overall goal of this research is to determine the sites of interaction between tubulin and microtubule-stabilizing anti-mitotic agents. Taxol is the best known of the microtubule-stabilizing compounds but others such as the epothilones show great potential as anti-tumor agents. Knowledge of the binding site shared by taxol and other structurally diverse anti-mitotic compounds with similar taxol-like activity wilt be a great aid in the rational design of anti-tumor agents that bind to the taxol binding region of tubulin. Our approach is to use mutagenesis of yeast tubulin. Although tubulin from the budding yeast Saccharomyces cerevisiae does not bind taxol, we have been able to create strong taxol binding to yeast tubulin by mutating just five of the 124 amino acids that are different between yeast and mammalian beta-tubulin. We now plan a more comprehensive mutational analysis of the taxol-binding region to provide a thorough understanding of the interactions required for taxol, the epothilones, and other compounds to bind to this region of beta-tubulin. We plan to determine which of the five mutations we made are most responsible for taxol binding, and what other amino acids that have also been implicated in taxol binding, actually make a contribution. We will determine whether the mutations we create affect taxol binding, microtubule stability, or both. Our studies will determine the differences in binding interactions with tubulin amongst the microtubule-stabilizing antimitotic agents taxol, the epothilones, the eleutherobins, and discodermolide. By using taxol photoaffinity analogues we will determine what part of the taxol molecule is likely to make contact with the mutated regions of beta-tubulin. Finally, we will study the taxol binding properties of tubulin from the fission yeast Schizosaccharomyces pombe in which the taxol binding region appears to more closely resemble that of mammalian tubulin.